Agios Pharmaceuticals Inc (AGIO) 103.51 $AGIO Insider

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:29 PM

Agios Pharmaceuticals Inc (AGIO) 103.51 $AGIO

Insider Trading Alert - AGIO, NXTM And EBIX Traded By Insiders
at The Street - Mon Apr 20, 9:48AM CDT
Stocks with insider trader activity include AGIO, NXTM and EBIX
NXTM: 18.85 (+0.03), EBIX: 29.77 (+0.86), AGIO: 103.51 (-4.12)

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015
M2 - Wed Apr 01, 5:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h5z2hq/bile_duct_cancer) has announced the addition of the "Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015" report to their offering. This report provides elemental information and data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bile Duct Cancer (Cholangiocarcinoma). Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Top Companies Participating in Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials - Sanofi - Eli Lilly and Company - AstraZeneca PLC - GlaxoSmithKline plc - OncoTherapy Science, Inc. - Daiichi Sankyo Company, Limited - CellAct Pharma GmbH - C. H. Boehringer Sohn AG & Co. KG - Astellas US Holding, Inc. - Agios Pharmaceuticals, Inc. For more information visit http://www.researchandmarkets.com/research/h5...uct_cancer
AZN: 73.35 (+0.65), LLY: 72.30 (+0.09), AGIO: 103.51 (-4.12), GSK: 46.57 (-0.67)

Agios' PK Deficiency Drug AG-348 Gets Orphan Drug Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:50PM CDT
Agios Pharmaceuticals (AGIO) announced that its PK deficiency candidate, AG-348 has been granted orphan drug status by the FDA.
LCI: 66.45 (-0.28), CBM: 42.07 (-0.65), AGIO: 103.51 (-4.12), CELG: 115.54 (+0.72)

Agios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency
GlobeNewswire - Tue Mar 24, 2:04PM CDT
- PK deficiency is a severe and rare genetic disease with currently no approved or disease modifying treatments -
AGIO: 103.51 (-4.12)

Jim Cramer -- 19 Companies That Could Get Acquired in 2015
at The Street - Mon Mar 23, 11:35AM CDT
2015 is turning into an epic year for deals. Owning the stock of a likely takeover candidate can result in tidy profits. Jim Cramer names 19 companies to watch.
KMI: 44.07 (+0.46), MNST: 139.91 (+0.06), MDLZ: 36.83 (+0.30), AWAY: 32.27 (+0.76), NKE: 100.15 (-0.14), GRUB: 45.84 (-0.45), GMCR: 114.53 (+2.27), SKX: 75.84 (+1.03), KRFT: 88.25 (-0.22), K: 63.98 (+0.12), JACK: 91.32 (-0.27), YHOO: 43.97 (-0.52), CMG: 641.23 (-51.29), HAWK: 36.12 (+0.28), TWTR: 51.73 (+0.41), Z: 99.00 (+1.96), CST: 43.54 (-0.12), KO: 41.31 (+0.53), BWP: 16.73 (+0.07), NCR: 30.07 (+0.50), VFC: 73.91 (-0.42), TRIP: 82.71 (+1.43), FRGI: 59.39 (-0.22), LULU: 65.67 (-0.68), DRI: 65.20 (-0.09), CELG: 115.54 (+0.72), ADS: 308.33 (+3.47), WWAV: 45.54 (-0.56), HAIN: 61.74 (-0.13), MPC: 102.13 (+2.12), CPB: 46.11 (+0.06), AGIO: 103.51 (-4.12), PAY: 35.88 (-0.06), YELP: 50.45 (+1.14), GIS: 56.21 (+0.10)

Critical Alerts For Advanced Micro Devices, DigitalGlobe, Infoblox, Peabody Energy and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Mar 02, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for AMD, DGI, BLOX, BTU and AGIO.
BTU: 4.87 (+0.06), DGI: 33.65 (-0.45), AMD: 2.28 (-0.07), BLOX: 24.25 (+0.11), AGIO: 103.51 (-4.12)

What Makes Agios Pharmaceuticals (AGIO) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:55AM CST
It may not be a good decision to keep Agios Pharmaceuticals (AGIO) in your portfolio anymore, at least if you don’t have a long time horizon to wait
ABAX: 63.25 (-0.09), AGIO: 103.51 (-4.12)

The 1 Stock You've Been Overlooking for Your Roth IRA
Motley Fool Staff - Motley Fool - Fri Feb 20, 6:04AM CST
If you're investing your money through a Roth IRA, you're already on your way to achieving long-term financial security, but don't pat yourself on the back yet. To maximize your Roth IRA, you also need to own the right investments. If you're not sure...
DIS: 107.94 (+0.26), AGIO: 103.51 (-4.12), SPWR: 34.74 (+0.28), CELG: 115.54 (+0.72)

Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 18, 5:30PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UIHC: 20.78 (+0.18), SONS: 7.89 (+0.05), HOLI: 23.74 (+0.58), GRMN: 46.95 (-0.62), ORPN: 6.37 (-0.04), SYKE: 24.97 (+0.03), ENPH: 13.38 (+0.03), USTR: 41.62 (+0.15), FOSL: 82.49 (+0.68), AFMD: 7.94 (+0.11), AGIO: 103.51 (-4.12), ISTR: 15.96 (-0.04), BCOR: 13.88 (+0.06), UCTT: 5.66 (+0.14)

Company News for February 18, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:10AM CST
Companies in the News are: QSR,WM,LECO,AGIO
QSR: 39.36 (+0.67), AGIO: 103.51 (-4.12), LECO: 66.32 (-0.15), WM: 52.61 (-0.23)

Why Agios Pharmaceuticals Inc Shares Burst Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Feb 17, 4:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: shares dropped by more than 10%...
AGIO: 103.51 (-4.12), CELG: 115.54 (+0.72)

Celgene: A Follow-Up To My Bullish Article Of Last Spring
DoctoRx - at Seeking Alpha - Tue Feb 17, 3:09PM CST

AMGN: 169.10 (+0.64), AGIO: 103.51 (-4.12), CELG: 115.54 (+0.72), XLRN: 33.67 (-0.02)

Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 17, 11:19AM CST

AGIO: 103.51 (-4.12)

Agios (AGIO) Reports Wider-than-Expected Loss in Q4 - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 17, 8:03AM CST
Agios (AGIO) Reports Wider-than-Expected Loss in Q4
AGIO: 103.51 (-4.12)

Agios Pharma ups revenues 157% in FY14
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 7:18AM CST

AGIO: 103.51 (-4.12)

Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Tue Feb 17, 6:58AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2014. In addition, Agios highlighted selected corporate milestones and updated guidance for its lead clinical development programs:
AGIO: 103.51 (-4.12)

Agios Pharmaceuticals reports 4Q loss
Automated Insights - Tue Feb 17, 6:48AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Tuesday reported a loss of $26.7 million in its fourth quarter.
AGIO: 103.51 (-4.12)

Agios Pharmaceuticals misses by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 6:33AM CST

AGIO: 103.51 (-4.12)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 16, 4:30PM CST

MDT: 78.01 (+0.93), GPC: 93.02 (+0.57), WLT: 0.57 (-0.01), PES: 6.26 (-0.24), TGH: 31.21 (-0.04), CRY: 10.11 (-0.08), LECO: 66.32 (-0.15), MGM: 22.03 (+0.32), USAC: 22.00 (unch), MNTA: 18.62 (+0.56), WM: 52.61 (-0.23), TTS: 14.52 (-0.33), ACC: 41.74 (+0.47), QSR: 39.36 (+0.67), VDSI: 25.11 (-0.58), GT: 27.65 (-0.08), WWW: 32.81 (+0.21), WRI: 34.43 (+0.31), ALE: 50.65 (-0.22), AGIO: 103.51 (-4.12), NHI: 68.86 (+0.33), VNR: 15.85 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

FSS Unveils AI Tool to Simplify Bankruptcy Cases

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....

Vortex Expands UK Reach with Torrent Acquisition Boost

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

University of Phoenix Grads Shine in Job Readiness

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Local Expertise in Real Estate: Key to Success?

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

Reel Wheels: Hollywood's Iconic Car Collection Unveiled

Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...

Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

EPR Fireworks, Schedule2.IT Enhance EMS Integration

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Crucial Insights for South GA Home Insurance Choices

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...